Vera Therapeutics Q3 EPS $(1.30) Beats $(1.62) Estimate, Sales $10.277M Beat $3.398M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(1.30) per share which beat the analyst consensus estimate of $(1.62) by 19.75 percent. This is a 3.17 percent decrease over losses of $(1.26) per share from
Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(1.30) per share which beat the analyst consensus estimate of $(1.62) by 19.75 percent. This is a 3.17 percent decrease over losses of $(1.26) per share from the same period last year. The company reported quarterly sales of $10.277 million which beat the analyst consensus estimate of $3.398 million by 202.42 percent.